SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 89 filers reported holding SERES THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,823,000 | -8.1% | 487,164 | +14.1% | 0.00% | 0.0% |
Q3 2016 | $5,247,000 | -35.2% | 426,951 | +53.1% | 0.00% | 0.0% |
Q2 2016 | $8,102,000 | +59.7% | 278,898 | +46.0% | 0.00% | 0.0% |
Q1 2016 | $5,072,000 | -24.7% | 190,973 | -0.5% | 0.00% | 0.0% |
Q4 2015 | $6,737,000 | +43.1% | 192,006 | +20.9% | 0.00% | 0.0% |
Q3 2015 | $4,709,000 | – | 158,859 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
Geduld E E | 15,000 | $149,000 | 0.08% |
Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |